United Kingdom Archives - LifeScienceHistory.com

Cartoon Illustrating “The NIH and U.S. Healthcare in Crisis” Published

On Apr. 21, 2025, LifeScienceHistory.com published the cartoon: “The National Institutes of Health (NIH) and U.S. Healthcare in…

Thousands of people could benefit from new twice-a-day tablet for advanced breast cancer

On Apr. 11, 2025, the UK National Institute for Health and Care Excellence (NICE) recommended capivasertib (also called…

UK Report highlights Two Dozen pathogens of greatest risk to public health

On Mar. 25. 2025, the UK Health Security Agency (UKHSA) published its view on the pathogen families that…

Rice labs tapped for brain research by UK funding agency with multimillion-dollar awards

On Jan. 21, 2025, Rice University announced that four research groups are part of an inaugural cohort of…

Study pinpoints depression genes across ethnicities

On Jan. 14, 2025, an international research team led by the University of Edinburgh reported new genetic risk…

Tumour DNA in the blood can predict lung cancer outcome

On Jan. 13, 2025, scientists from the Francis Crick Institute, UCL, UCLH and Personalis announced they have found…

Genetic cause for main type of hearing loss in children with Down syndrome identified

On Jan. 7, 2025, researchers at the Francis Crick Institute, MRC Harwell Institute and UCL Queen Square Institute…

Biotechnology | Diagnostics | Disease | Life Science News | Therapeutics

First new treatment for asthma attacks in 50 years

On Nov. 28, 2024, scientists from King’s College London reported that an injection given during some asthma and…

Artificial Intelligence | Biotechnology | Diagnostics | Life Science News | Therapeutics

AI can predict study results better than human experts

On Nov. 27, 2024, a study led by the University College London reported that large language models, a…

Vaccine doses allocated to African countries hardest hit by mpox surge

On Nov. 9, 2024, the World Health Organization announced that three additional countries had confirmed travel-related cases of…

H5N1 and H5N5 Avian influenza confirmed in poultry in England

On Nov. 6, 2024, The United Kingdom’s Chief Veterinary Officers was urging all bird keepers to follow scrupulous…

Biotechnology | Diagnostics | Disease | Life Science News

Restricting sugar before birth and in early childhood greatly reduces risk of chronic disease later in life

On Nov. 1, 2024, researchers reported results from a study that show a low-sugar diet during pregnancy and…

Nobel Prize in Chemistry awarded to David Baker “for computational protein design”; Demis Hassabis and John M. Jumper “for protein structure prediction”

On Oct. 9, 2024, the Nobel Foundation awarded the Nobel Prize in Chemistry: one half to David Baker,…

Biotechnology | Disease | Life Science News | Neurology | Therapeutics

first drug approved for early Alzheimer’s disease in the UK

On Aug. 22, 2024, the Medicines and Healthcare Products Regulatory Agency (MHRA) announced it had licensed the immunotherapy…

Biotechnology | Disease | FDA | Life Science News | Therapeutics

Swissmedic Authorises CSL’s HEMGENIX® (etranacogene dezaparvovec) as First Gene Therapy for Hemophilia B

On Jan. 15, 2024, CSL announced that Swissmedic had authorised HEMGENIX® (etranacogene dezaparvovec), the first and currently only gene…

WHO announced influenza A(H1N2) variant virus infection in the Great Britain and Northern Ireland

On Dec. 1, 2023, the World Health Organization (WHO) announced that the International Health Regulations National Focal Point…

Biotechnology | CRISPR | Life Science News | Therapeutics

Vertex and CRISPR Therapeutics announced authorization of first CRISPR/Cas9 gene-edited therapy by UK MHRA for treatment of Sickle Cell Disease

On Nov. 16, 2023, Vertex and CRISPR Therapeutics announced that the United Kingdom (U.K.) Medicines and Healthcare products…

Biotechnology | COVID-19 | Infectious Disease | Life Science News | Vaccine

Novavax received full Marketing Authorization for potype COVID-19 vaccine Nuvaxovid in UK

On Oct. 18, 2023, Novavax announced that the Medicines and Healthcare products Regulatory Agency (MHRA) in the United…

The United Kingdom announced the Vaccine Development and Evaluation Centre

On Aug. 7, 2023, the United Kingdom Health and Security Agency announced the Vaccine Development and Evaluation Centre…

UK Animal and Plant Health Agency reported asymptomatic human detections of influenza A (H5N1)

On Jul. 14, 2023, the UK Animal and Plant Health Agency reported that additional asymptomatic human detections of…

WHO reported Avian influenza A(H5N1) in United Kingdom of Great Britain and Northern Ireland

On May 30, 2023, the United Kingdom of Great Britain and Northern Ireland reported to the World Health…

Life Science History

BioNTech announced strategic partnership with UK Government to provide up to 10,000 patients with personalized mRNA cancer immunotherapies

On Jan. 5, 2023, BioNTech announced that the Company had signed a Memorandum of Understanding with the Government…

Biotechnology | COVID-19 | Infectious Disease | Life Science News | Vaccine

Spanish, Italian and French Health Authorities expanded recommendations for use of Novavax COVID-19 vaccine

On Jan. 5, 2023, Novavax announced that Spain’s Public Health Commission, Italy’s Ministry of Health, and France’s Haute…

Biotechnology | COVID-19 | Infectious Disease | Life Science News | Vaccine

Moderna finalized strategic partnership with UK government

On Dec. 21, 2022, Moderna announced the the finalization of a strategic partnership with the United Kingdom (UK)…

Hutchinson Cancer Center leads large-scale review of COVID-19 clinical trials that highlights multiple disparities

On Dec. 5, 2022, the Fred Hutchinson Cancer Center announced that according to a new meta-analysis women were…

Novavax Nuvaxovid COVID-19 Vaccine authorized in the United Kingdom for use as a booster in adults

On Nov. 9, 2022, Novavax announced that the Medicines and Healthcare products Regulatory Agency (MHRA) in the United…

Study confirmed link between COVID-19 vaccination and temporary increase in menstrual cycle length

On Sept. 27, 2022, the National Institutes of Health (NIH) announced that a large international study had confirmed…

Biotechnology | COVID-19 | Infectious Disease | Life Science News | Vaccine

Novavax made one million doses of Nuvaxovid available for use in the United Kingdom

On Sept. 27, 2022, Novavax announced that an initial one million doses of Nuvaxovid (NVX-CoV2373) COVID-19 vaccine were…

Biotechnology | COVID-19 | Infectious Disease | Life Science News | Vaccine

Novavax Nuvaxovid COVID-19 vaccine granted expanded conditional marketing authorization in UK for use in adolescents aged 12 through 17

On Aug. 26, 2022, Novavax announced that the Medicines and Healthcare products Regulatory Agency (MHRA) in the United…

Biotechnology | COVID-19 | Life Science News | Vaccine

Novavax filed in the UK for expanded conditional Marketing Authorization of COVID-19 vaccination booster in adult

On Jun. 2, 2022, Novavax announced the submission of a request to the Medicines and Healthcare products Regulatory…

United Kingdom

Cartoon Illustrating “The NIH and U.S. Healthcare in Crisis” Published

Thousands of people could benefit from new twice-a-day tablet for advanced breast cancer

UK Report highlights Two Dozen pathogens of greatest risk to public health

Rice labs tapped for brain research by UK funding agency with multimillion-dollar awards

Study pinpoints depression genes across ethnicities

Tumour DNA in the blood can predict lung cancer outcome

Genetic cause for main type of hearing loss in children with Down syndrome identified

First new treatment for asthma attacks in 50 years

AI can predict study results better than human experts

Vaccine doses allocated to African countries hardest hit by mpox surge

H5N1 and H5N5 Avian influenza confirmed in poultry in England

Restricting sugar before birth and in early childhood greatly reduces risk of chronic disease later in life

Nobel Prize in Chemistry awarded to David Baker “for computational protein design”; Demis Hassabis and John M. Jumper “for protein structure prediction”

first drug approved for early Alzheimer’s disease in the UK

Swissmedic Authorises CSL’s HEMGENIX® (etranacogene dezaparvovec) as First Gene Therapy for Hemophilia B

WHO announced influenza A(H1N2) variant virus infection in the Great Britain and Northern Ireland

Vertex and CRISPR Therapeutics announced authorization of first CRISPR/Cas9 gene-edited therapy by UK MHRA for treatment of Sickle Cell Disease

Novavax received full Marketing Authorization for potype COVID-19 vaccine Nuvaxovid in UK

The United Kingdom announced the Vaccine Development and Evaluation Centre

UK Animal and Plant Health Agency reported asymptomatic human detections of influenza A (H5N1)

WHO reported Avian influenza A(H5N1) in United Kingdom of Great Britain and Northern Ireland

BioNTech announced strategic partnership with UK Government to provide up to 10,000 patients with personalized mRNA cancer immunotherapies

Spanish, Italian and French Health Authorities expanded recommendations for use of Novavax COVID-19 vaccine

Moderna finalized strategic partnership with UK government

Hutchinson Cancer Center leads large-scale review of COVID-19 clinical trials that highlights multiple disparities

Novavax Nuvaxovid COVID-19 Vaccine authorized in the United Kingdom for use as a booster in adults

Study confirmed link between COVID-19 vaccination and temporary increase in menstrual cycle length

Novavax made one million doses of Nuvaxovid available for use in the United Kingdom

Novavax Nuvaxovid COVID-19 vaccine granted expanded conditional marketing authorization in UK for use in adolescents aged 12 through 17

Novavax filed in the UK for expanded conditional Marketing Authorization of COVID-19 vaccination booster in adult

Subscribe to E-History

LifeScienceHistory.com

More

Advertising

Legal